Proactive Investors - Run By Investors For Investors

CannPal Animal Therapeutics major shareholder increases stake

An Australian fund manager has increased its stake to 19.61% in the company.
growth concept
A number of board and management personnel have been buying shares recently

CannPal Animal Therapeutics Ltd (ASX:CP1) has had one of its major shareholders, Merchant Funds Management, increase its stake to 19.61% from 18.61%.

The increase was the result of a series of on-market trades, the most recent being the purchase of 1 million shares last Thursday 16 May for $145,478.

Merchant is a boutique Perth-based fund manager focused on early-stage ASX opportunities.

READ: CannPal Animal Therapeutics files new patent application as industry-leading research is recognised

The buying activity from Merchant follows purchases from a number of CannPal board members.

The most recent purchase was from founder and managing director Layton Mills who purchased 65,000 shares via on-market trades earlier this month.

The share purchase from Mills follows purchases from Max Johnston in March, chairman Geoff Starr in February, and Robert Clifford in January.

CannPal is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals such as dogs and cats.

CPAT-01 is the company’s lead drug candidate under development targeting pain and inflammation control in dogs.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CP1 profile View Profile

CannPal Animal Therapeutics Ltd Timeline

Related Articles

windmill
May 08 2019
TGOD has been busy building out its facilities in Ontario, Quebec, and Jamaica and expects to reach combined production of 219,000 kilograms of cannabis around 2021
A cannabis plant shown next to an oil-based product
April 24 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use